现代消化及介入诊疗
現代消化及介入診療
현대소화급개입진료
Modern Digestion & Intervention
2015年
5期
485-488
,共4页
恶性胆道梗阻%覆膜支架%无膜支架%生存时间%通畅时间
噁性膽道梗阻%覆膜支架%無膜支架%生存時間%通暢時間
악성담도경조%복막지가%무막지가%생존시간%통창시간
Malignant biliary obstruction%Coated metallic stent%Non coated metallic stent%Survival time%Patency time
目的:探讨经内镜置入覆膜金属支架和非覆膜金属支架治疗恶性胆道梗阻的临床疗效。方法回顾分析我院2007年5月至2012年5月126例经内镜置入金属支架治疗恶性胆道梗阻患者,其中覆膜组59例,无膜组67例。对两组患者的内镜插管成功率、治疗效果、生存时间、支架通畅时间、并发症发生率进行分析和比较。结果内镜插管成功率在覆膜组和无膜组均为100%。覆膜组和无膜组的总引流有效率、术后胰腺炎发生率、术后胆囊炎发生率分别为96.6%vs 94.0%(P>0.05)、13.6%vs 1.5%(P<0.05)、11.9%vs 1.5%(P<0.05)。覆膜组和无膜组的中位生存时间分别为389 d和372 d(P<0.05),中位支架通畅时间分别为368 d和190 d(P<0.05)。结论胆道金属支架可解除中下段胆总管恶性梗阻,延长患者生存时间。覆膜金属支架通畅时间明显优于非覆膜金属支架,术后胰腺炎和胆囊炎发生率均明显高于非覆膜金属支架。
目的:探討經內鏡置入覆膜金屬支架和非覆膜金屬支架治療噁性膽道梗阻的臨床療效。方法迴顧分析我院2007年5月至2012年5月126例經內鏡置入金屬支架治療噁性膽道梗阻患者,其中覆膜組59例,無膜組67例。對兩組患者的內鏡插管成功率、治療效果、生存時間、支架通暢時間、併髮癥髮生率進行分析和比較。結果內鏡插管成功率在覆膜組和無膜組均為100%。覆膜組和無膜組的總引流有效率、術後胰腺炎髮生率、術後膽囊炎髮生率分彆為96.6%vs 94.0%(P>0.05)、13.6%vs 1.5%(P<0.05)、11.9%vs 1.5%(P<0.05)。覆膜組和無膜組的中位生存時間分彆為389 d和372 d(P<0.05),中位支架通暢時間分彆為368 d和190 d(P<0.05)。結論膽道金屬支架可解除中下段膽總管噁性梗阻,延長患者生存時間。覆膜金屬支架通暢時間明顯優于非覆膜金屬支架,術後胰腺炎和膽囊炎髮生率均明顯高于非覆膜金屬支架。
목적:탐토경내경치입복막금속지가화비복막금속지가치료악성담도경조적림상료효。방법회고분석아원2007년5월지2012년5월126례경내경치입금속지가치료악성담도경조환자,기중복막조59례,무막조67례。대량조환자적내경삽관성공솔、치료효과、생존시간、지가통창시간、병발증발생솔진행분석화비교。결과내경삽관성공솔재복막조화무막조균위100%。복막조화무막조적총인류유효솔、술후이선염발생솔、술후담낭염발생솔분별위96.6%vs 94.0%(P>0.05)、13.6%vs 1.5%(P<0.05)、11.9%vs 1.5%(P<0.05)。복막조화무막조적중위생존시간분별위389 d화372 d(P<0.05),중위지가통창시간분별위368 d화190 d(P<0.05)。결론담도금속지가가해제중하단담총관악성경조,연장환자생존시간。복막금속지가통창시간명현우우비복막금속지가,술후이선염화담낭염발생솔균명현고우비복막금속지가。
Objective To compare the clinical results of coated and non coated metallic biliary stents in patients with malignant biliary obstruction. Methods One hundred and twenty six patients with malignant bil-iary obstruction were treated with coated stents (59 cases) and non coated stents (67 cases) under endoscopy. The intubation success rate, therapeutic efficacy, survival time, stent patency time and complications rate were analyzed and compared. Results The intubation success rates were 100%in both two groups. The overall drainage rates、pancreatitis rates and cholecystitis rates in coated and non coated groups were 96.6%vs 94.0%(P>0.05), 13.6%vs 1.5%(P<0.05), 11.9%vs 1.5%(P<0.05). The median survival time was 389 days in the coated group, and 372 days in the non coated group(P>0.05). The median stent patency time was 368 days in the coated group, and 190 days in the non coated group(P<0.05). Conclusion The metallic biliary stent could effectively reduce distal malignant biliary obstruction and prolong the survival time of the patients. The paten-cy time of coated metallic stent could be obviously longer than that of non coated metallic stent. Pancreatitis and cholecystitis could happen more often with coated metallic stent compared with non coated metallic stent.